About Us

illumiSonics is a University of Waterloo spinout developing a patented Multi-Laser Imaging (MLI™) platform for label-free tissue diagnostics. Our technology is protected by 40+ issued patents and validated by 56+ peer-reviewed publications, with demonstrated diagnostic equivalence to standard-of-care H&E in skin and breast cancer.

Meet The Team

View

John Mackey

CEO & Director

View

Glen Mackey

CFO & Director

View

Mike Bishop

Director, Product Dev. and Hardware

View

Kristof Subryan

Director, Software Architecture

Jill Stefanelli

Advisor in Digital & Molecular Pathology

Deepak Dinakaran

Director, Molecular Imaging

View

Islam Mohamed

Clinical Advisor

View

Benjamin Ecclestone

Principal Research Scientist

View

James Tweel

Principal Research Scientist

View

Alex Tummon Simmons

Research Scientist

View

Krystal Li

Product Developer

View

Stephanie Clarke

Executive Assistant

Our Partners

Home of illumiSonics' foundational 8-year R&D partnership and the world-class photonics talent pipeline behind MLI™. Ranked by PitchBook as Canada's top university for venture-capital-backed entrepreneurs.

University of Waterloo's flagship startup incubator and the largest free startup incubator in North America. A Velocity company affiliation signals selection by one of Canada's most rigorous early-stage vetting programs for deep-tech founders.

Canada's national network for image-guided therapy and AI innovation, founded by Sunnybrook Research Institute and backed by the Government of Canada's Strategic Innovation Fund. illumiSonics is a member company within Canada's premier medtech commercialization network.

Canada's #1 private business accelerator, with a dedicated medtech program supporting regulatory strategy, clinical validation, and scale-up. Over 650 companies supported, including Waterloo Region unicorns ApplyBoard and Faire.